跳至主要内容
临床试验/ITMCTR2200005762
ITMCTR2200005762尚未招募1 期

Clinical study on the effect of abdominal tuina on metabolic syndrome patients with heat stagnation of liver and stomach sydrome

Guang'anmen Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1)Aged 18 to 65 years (including borders), no gender limitation.
  • (2)Participants who meet the metabolic syndrome diagnostic criteria identified by International Diabetes Federation.
  • (3)Traditional Chinese medicine syndrome was heat stagnation of liver and stomach
  • (4)Participants have fasting blood glucose between 5.6 and 7.0 mmol/L, and/or 2h post-load glucose level less than 11.1 mmol/L. And no antidiabetic drugs are used to control the blood glucose level at present.
  • (5)Participants have triglyceride between 1.7 and 5.6 mmol/L,high density lipoprotein cholesterol less than 1.03 mmol/L (male) and 1.29 mmol/L (female), total cholesterol less than 6.2 mmol/L and low density lipoprotein cholesterol less than 4.1 mmol/L. And no lipid-regulating drugs are used to control the blood lipid level at present.
  • (6)The blood pressure range of the participants are 140-159/90-99 mmHg, cardiovascular risk level stratified into low-risk, and no antihypertensive drugs are used to control the blood pressure at present.
  • (7)Sign the informed consent by the participants.

排除标准

  • (1)Other primary diseases including chronic kidney disease, chronic liver disease and hypothyroidism lead to abnormalities in blood glucose, blood lipids and blood pressure.
  • (2)Combined with severe cardiovascular and cerebrovascular diseases, such as heart failure, severe hypertension, cerebral hemorrhage, etc.
  • (3)Combined with severe liver dysfunction (ALT or AST more than 3 times the upper limit of normal value), malignant tumors and autoimmune diseases.
  • (4)Pregnancy, preparing for pregnancy or breastfeeding women.
  • (5)Allergic constitution.
  • (6)Those who are participating in other clinical trials or have participated in other drug clinical trials within one month after the end.
  • (7)The researcher judges that it is not suitable to enter the research due to other reasons.

研究者

相似试验